Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rader

Showing results (81-90 of 1,023) with videos related to

Pageof 103
Sort By:
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Annual Review of Medicine|February 8, 2018
New Therapeutic Approaches for Familial HypercholesterolemiaEzim Ajufo, Daniel J Rader
Nature Medicine|October 6, 2007
'Multipurpose oxidase' in atherogenesisDaniel J Rader, Harry Ischiropoulos
Gastroenterology|May 15, 2007
Obesity and atherogenic dyslipidemiaVaneeta Bamba, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Annales De Biologie Clinique|February 5, 2009
[Laboratory assessment of HDL heterogeneity and function]R Movva, D J Rader
Nature|February 22, 2008
Translating molecular discoveries into new therapies for atherosclerosisDaniel J Rader, Alan Daugherty
Circulation Research|May 24, 2014
Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modifiedAli Javaheri, Daniel J Rader
Current Opinion in Lipidology|October 17, 2012
Effect of interleukin 1β inhibition in cardiovascular diseaseArman Qamar, Daniel J Rader
Lancet (London, England)|December 14, 2001
Cholesterol and all-cause mortality in HonoluluM Cuchel, D J Rader
Pageof 103

Showing results (81-90 of 1,023) with videos related to

Sort By:
Pageof 103
Circulation|March 1, 2006
Emerging therapies targeting high-density lipoprotein metabolism and reverse cholesterol transportDanielle Duffy, Daniel J Rader
Annual Review of Medicine|February 8, 2018
New Therapeutic Approaches for Familial HypercholesterolemiaEzim Ajufo, Daniel J Rader
Nature Medicine|October 6, 2007
'Multipurpose oxidase' in atherogenesisDaniel J Rader, Harry Ischiropoulos
Gastroenterology|May 15, 2007
Obesity and atherogenic dyslipidemiaVaneeta Bamba, Daniel J Rader
Circulation|June 1, 2006
Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?Marina Cuchel, Daniel J Rader
Annales De Biologie Clinique|February 5, 2009
[Laboratory assessment of HDL heterogeneity and function]R Movva, D J Rader
Nature|February 22, 2008
Translating molecular discoveries into new therapies for atherosclerosisDaniel J Rader, Alan Daugherty
Circulation Research|May 24, 2014
Apolipoprotein A-I and cholesterol efflux: the good, the bad, and the modifiedAli Javaheri, Daniel J Rader
Current Opinion in Lipidology|October 17, 2012
Effect of interleukin 1β inhibition in cardiovascular diseaseArman Qamar, Daniel J Rader
Lancet (London, England)|December 14, 2001
Cholesterol and all-cause mortality in HonoluluM Cuchel, D J Rader
Pageof 103